Morgan Celia J A, Riccelli Marcio, Maitland Charles H, Curran H Valerie
Clinical Psychopharmacology Unit, Clinical Health Psychology, University College London, Gower St., London WC1E 6BT, UK.
Drug Alcohol Depend. 2004 Sep 6;75(3):301-8. doi: 10.1016/j.drugalcdep.2004.03.006.
Ketamine is an N-methyl-d-aspartate (NMDA)-receptor antagonist that is increasingly being used as a recreational drug. Previous research has shown gross generalised verbal memory impairments persisting 3 days after ketamine use in chronic users, however episodic memory has not specifically investigated in this population.
To determine whether ketamine, on the night of drug use (day 0) and 3 days later, is associated with impaired episodic memory as assessed by a source memory task.
Twenty ketamine users and 20 poly-drug controls were compared on a source memory task both on day 0 and 3. Participants also completed questionnaires on both days indexing schizophrenic-like and dissociative symptoms.
On day 0, ketamine abusers were impaired on both source memory and item recognition and scored more highly on schizophrenic and dissociative symptom scales compared to poly-drug controls. On day 3 ketamine abusers only displayed source memory impairments and these positively correlated with the level of schizophrenic-like symptoms on day 0. No differences on day 3 in schizophrenic-like or dissociative symptoms were observed.
Ketamine abusers exhibit a persisting deficit in source memory on day 3 but not in item recognition. These findings suggest that repeated use of ketamine produces chronic impairments to episodic memory.
氯胺酮是一种N-甲基-D-天冬氨酸(NMDA)受体拮抗剂,越来越多地被用作消遣性药物。先前的研究表明,长期使用者在使用氯胺酮后3天,会持续出现严重的一般性言语记忆障碍,然而,情景记忆在这一人群中尚未得到专门研究。
通过源记忆任务评估,确定在用药当晚(第0天)和3天后,氯胺酮是否与情景记忆受损有关。
比较20名氯胺酮使用者和20名多药使用者在第0天和第3天的源记忆任务表现。参与者在这两天还完成了关于精神分裂症样症状和解离症状的问卷调查。
在第0天,与多药使用者相比,氯胺酮滥用者在源记忆和项目识别方面均受损,且在精神分裂症和解离症状量表上得分更高。在第3天,氯胺酮滥用者仅表现出源记忆受损,且这些受损与第0天的精神分裂症样症状水平呈正相关。在第3天,未观察到精神分裂症样症状或解离症状的差异。
氯胺酮滥用者在第3天表现出持续的源记忆缺陷,但在项目识别方面没有。这些发现表明,反复使用氯胺酮会对情景记忆产生慢性损害。